I agree that this site is using cookies. You can find further informations here.
X
Kunz Coyne, Ashlan J.
62  results:
Search for persons X
?
1

Eravacycline, the first four years: health outcomes and tol..:

Kunz Coyne, Ashlan J. ; Alosaimy, Sara ; Lucas, Kristen...
Microbiology Spectrum.  12 (2024)  1 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
2

Cefiderocol: early clinical experience for multi-drug resis..:

El Ghali, Amer ; Kunz Coyne, Ashlan J. ; Lucas, Kristen...
Microbiology Spectrum.  12 (2024)  2 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
3

Synergistic bactericidal effects of phage-enhanced antibiot..:

Kunz Coyne, Ashlan J. ; Stamper, Kyle ; Bleick, Callan...
Microbiology Spectrum.  12 (2024)  4 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
4

Risk Factors for Carbapenem-ResistantEnterobacteralesClinic..:

Rebold, Nicholas ; Lagnf, Abdalhamid M. ; Alosaimy, Sara...
Microbiology Spectrum.  11 (2023)  1 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
5

High-dose Cefepime vs Carbapenems for Bacteremia Caused by ..:

Kunz Coyne, Ashlan J ; El Ghali, Amer ; Lucas, Kristen...
Open Forum Infectious Diseases.  10 (2023)  3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
6

Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibit..:

El‐Ghali, Amer ; Kunz Coyne, Ashlan J. ; Caniff, Kaylee..
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  43 (2023)  6 - p. 502-513 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use..:

Kunz Coyne, Ashlan J ; Orzol, Carolina ; Veve, Michael P.
Open Forum Infectious Diseases.  10 (2023)  9 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
8

Optimization of Phage-Antibiotic Combinations against Staph..:

Kebriaei, Razieh ; Lehman, Susan M. ; Shah, Rahi M....
Microbiology Spectrum.  11 (2023)  3 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
9

2066. Synergistic Bacteriophage-Antibiotic Combinations Aga..:

Kunz Coyne, Ashlan J ; Stamper, Kyle ; Bleick, Callan...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
10

The Pharmacokinetic and Pharmacodynamic Properties of Antit..:

, In: Integrated Science; Tuberculosis,
Kunz Coyne, Ashlan J. ; Casapao, Anthony M. ; Egelund, Eric F. - p. 257-275 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Post‐graduate pharmacy fellowships: The current state of af..:

Elmes, Abigail T. ; Holger, Dana J. ; Cieslak, Karolina...
JACCP:JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.  6 (2023)  2 - p. 145-153 , 2023
Link: https://doi.org/10.1002/..
 
?
12

Steno‐sphere: Navigating the enigmatic world of emerging mu..:

Kunz Coyne, Ashlan J. ; Herbin, Shelbye ; Caniff, Kaylee.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  43 (2023)  8 - p. 833-846 , 2023
Link: https://doi.org/10.1002/..
 
?
13

1033. Unexpected Allies: Vancomycin and Cefazolin Combinati..:

Caniff, Kaylee E ; Kunz Coyne, Ashlan J ; Rybak, Michael J
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

Evaluation of Bacteriophage-Antibiotic Combination Therapy ..:

Lev, Katherine ; Kunz Coyne, Ashlan J. ; Kebriaei, Razieh...
Antibiotics.  11 (2022)  3 - p. 392 , 2022
Link: https://doi.org/10.3390/..
 
?
15

633. Eravacycline Use in Immunocompromised Patients: Multic..:

Kunz Coyne, Ashlan J ; Allosaimy, Sara ; Molina, Kyle C...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
1-15